Evaluation of TS and ENOSF1 Variants as a Biomarker in Response to Neoadjuvant Chemotherapy based on 5FU in Gastric Cancer Patients.

Khadijeh Arjmandi,Fereshteh Ameli,Iman Salahshourifar,Mhsen Esfandbod,Shiva Irani

Asian Pacific journal of cancer prevention : APJCP（2022）

引用 0|浏览2

暂无评分

摘要

This study established that the TS 5' UTR and ENOSF1 rs2612091 polymorphisms could be used to predict treatment response and overall survival in patients with gastric cancer who received neoadjuvant chemotherapy based on 5FU.

查看译文

关键词

Chemotherapy,ENOSF1,Gastric cancer,Personalized Medicine,TS

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要